Cortechs.ai | NeuroQuant PET

Rapid, automated regional tracer quantification and analysis of brain PET images

This tool provides researchers and physicians with a fully automated solution for quantifying Amyloid, Tau and FDG PET data.

Research Use Only – Not FDA Cleared

Cortechs.ai|NeuroQuant PET
Cortechs.ai|NeuroQuant PET
Cortechs.ai|NeuroQuant PET

Standardized reporting and Centiloid quantification for recognized biomarker support and disease monitoring

  • Automatically quantifies PET tracer bindings localized to brain structures for regional SUVR and z-score reporting.

  • Compatible with PET-MRI, PET-CT, or PET-only work flows.

  • Centiloid quantification for comparison across tracers and time.

Benefits

Cortechs.ai|NeuroQuant PET

Reporting options

Tracer specific reporting and regions of interest

Cortechs.ai|NeuroQuant PET

Clear visualization

Fusion images and anatomical overlays

Cortechs.ai|NeuroQuant PET

Automated processing

Automated cloud-based processing

NeuroQuant® PET reports

Powered by NeuroQuant® for trusted and proven brain segmentation analysis.

Related insights

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.
Scroll to Top